ClinicalTrials.gg
Drug

Ertugliflozin clinical trials

Also written MK-8835, PF-04971729 and Steglatro.

studies test it
37
open now
5
in phase 3
14
first study started
2009

How each study uses ertugliflozin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the ertugliflozin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
19 Dec 2017 · STEGLATRO · NDA 209803 (FDA, Drugs@FDA)
European Union
21 Mar 2018 · Steglatro · EMEA/H/C/004315 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ertugliflozin
16
Ertugliflozin 5 mg
12
Ertugliflozin 15 mg
7
Ertugliflozin 10 mg
5
SGLT2 inhibitor
2

Brand

Steglatro
4

Development codes

MK-8835
10
PF-04971729
7
MK-8355
1

Studies by the year they started

37 studies that test it; most in 2010 (6)

Studies that test ertugliflozin, by start year
YearStudies
20092
20106
20136
20144
20151
20182
20192
20205
20212
20234
20251
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
9
Phase 2
4
Phase 3
14
Phase 4
9

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 22 · Other 15

Merck Sharp & Dohme LLC (20) · Amsterdam UMC, location VUmc (3) · Stanford University (1) · Icahn School of Medicine at Mount Sinai (1) · Humanis Saglık Anonim Sirketi (1) · University Health Network, Toronto (1) · Asan Medical Center (1) · Soo Lim (1)

Often tested with

Tested in the same studies.

Metformin (1) · Sitagliptin (1) · Finerenone (1) · Semaglutide (1) · Benazepril (1) · Captopril (1) · Enalapril (1) · Fosinopril (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses ertugliflozin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 37

See all 37 studies that test ertugliflozin →

Codes

What other systems call ertugliflozin · ClinicalTrials.gg INT005995

  • MeSH (NLM) C570288ertugliflozinConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 6C282481IPERTUGLIFLOZINConfirmed FDA, NLM, Wikidata
  • RxNorm 1992672Confirmed FDA, Wikidata
  • Wikidata Q27077223ertugliflozinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C166925ErtugliflozinOne source FDA
  • DrugBank DB11827One source Wikidata

Also registered as ertugliflozin pidolate (UNII MLU731K321 · RxNorm 1992674).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.